Cleared Traditional

K852469 - SAF-D-FIB

K852469 is an FDA 510(k) clearance for SAF-D-FIB, manufactured by Medtronic Andover Medical, Inc.. The device is a Class 2 Cardiovascular device with product code DRX cleared through the Traditional 510(k) pathway after a 95-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1985
Decision
95d
Days
Class 2
Risk

K852469 is an FDA 510(k) clearance for the SAF-D-FIB. Classified as Electrode, Electrocardiograph (product code DRX), Class II - Special Controls.

Submitted by Medtronic Andover Medical, Inc. (Lowell, US). The FDA issued a Cleared decision on September 16, 1985 after a review of 95 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2360 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Medtronic Andover Medical, Inc. devices

FDA 510(k) Submission Details - K852469

510(k) Number K852469 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 13, 1985
Decision Date September 16, 1985
Days to Decision 95 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
30d faster than avg
Panel avg: 125d · This submission: 95d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRX Device Classification - Class 2, Special Controls

Product Code DRX Electrode, Electrocardiograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2360
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRX Electrode, Electrocardiograph

All 183
Devices cleared under the same product code (DRX) and FDA review panel - the closest regulatory comparables to K852469.
EM STRESS ELECTRODE
K860827 · Electromed Intl., Ltd. · May 1986
EM ELECTRODE
K853774 · Electromed Intl., Ltd. · Apr 1986
DE12 RAPID TRACE AT-REST DIAGNOSTIC ECG ELECTRODES
K853038 · Bio-Detek, Inc. · Jan 1986
FOAM ECG ELECTRODES
K852177 · Clinical Data, Inc. · Aug 1985
SYNKARA
K840445 · Lectec Corp. · May 1985
CANMED 102
K844099 · Medtronic Vascular · Dec 1984